Gene variants in Adiponectin and its receptors as risk factors for metabolic and cardiovascular disease [ 2008 - 2010 ]

Research Grant

Researchers: Prof Joseph Hung (Principal investigator) ,  Dr Brenda Powell ,  Dr Steven Wiltshire ,  Prof David Bruce ,  Prof John Beilby
View all 6 related researchers

Brief description Obesity has a major impact on the development of metabolic syndrome (MetS), type 2 diabetes (T2D), and cardiovascular disease (CVD). It is important to identify the molecular links between obesity and these conditions. Adiponectin, an adipocyte-specific hormone, is a likely molecular candidate because of its pleiotropic metabolic actions. We will investigate the role of adiponectin, the variants within its gene ADIPOQ, and that of its two receptors, in the development of MetS, T2D, and CVD.

Funding Amount $AUD 534,107.00

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant